Clinical trial proves effectiveness of FLASH treatment for pain reduction in cancer patients

University of Cincinnati Cancer Center researchers led a first-of-a-kind objective survey showing that a crab attraction known arsenic FLASH, oregon ultra-high-dose-rate proton beam radiation therapy, safely and efficaciously reduced symptom successful patients with crab that had dispersed to the bones successful the thorax (thoracic bony metastases). The survey was conducted successful collaboration with Cincinnati Children's, Varian Medical Systems and UC Health. The findings from the FAST-02 objective proceedings were published successful the diary Radiotherapy and Oncology.